Advanced GPCR Signalling: From Molecular Mechanisms to Therapeutic Opportunities

This symposium brings together leading academic and industrial experts in G protein–coupled receptor (GPCR) signaling to discuss recent advances in molecular mechanisms, signaling specificity, and implications for drug discovery. The program is particularly relevant for PhD students interested in molecular pharmacology, computation drug discovery, and translational aspects of GPCR biology.

Symposium programme

10:00

Introduction
Assoc. Prof. Alexander S. Hauser, Department of Drug Design and Pharmacology
10:10

Terra Incognita of Neuronal GPCR Signaling
Prof. Kirill Martemyanov, Department of Physiology & Biophysics, University of Miami
10:50 

Rapid Traversal of Vast Chemical Space Using Machine Learning-Guided Docking
Senior Researcher Israel Cabeza de Vaca, Uppsala University
11:10

GPCR drug discovery from an industry perspective
Principal Scientist Thor Christian Møller, Novo Nordisk
11:30

Metabolites in Signaling and Disease
Prof. Thue Schwartz, Novo Nordisk Foundation Center for Basic Metabolic Research
11:50

Discussion and closing remarks

The symposium is organized on behalf of the graduate programme in pharmaceutical sciences, Drug Research Academy, by Alexander S. Hausen, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen.

The symposium is free of charge and open for attendance by all interested parties. It is not necessary to pre-register.